LINE
Lineage, Inc.
36.30$
-2.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -0.8% | +0.2% | +2.7% | -3.1% | +0.6% | +3.6% | -1.3% | -0.1% | -0.7% | -0.8% | |
| – | – | -0.3% | +6.9% | +19.4% | -19.6% | +8.2% | -3.0% | -4.9% | -3.4% | +1.9% | -1.7% | |
| – | – | +34.1% | -20.0% | +460.3% | -57.7% | +12.7% | -58.5% | -7.4% | -12.0% | +1.5% | -13.4% | |
| – | – | +34.1% | -20.0% | +460.3% | -57.7% | +12.7% | -58.5% | -7.4% | -12.0% | +1.5% | -13.4% | |
| – | – | -3.9% | +8.8% | -5.6% | -8.3% | +2.5% | +5.2% | -3.8% | +4.6% | +2.3% | +0.3% | |
| – | – | -1.8% | +2.4% | +1.7% | +6.9% | -6.4% | -0.6% | -4.0% | -13.2% | -5.5% | -10.9% | |
| – | – | -0.6% | -0.4% | +2.5% | -3.1% | +1.2% | +3.7% | -0.9% | -0.2% | -0.8% | -0.3% | |
| – | – | -2.5% | -2.4% | +0.2% | -7.7% | -1.0% | +3.0% | -3.0% | -2.3% | -3.5% | -3.0% | |
| – | – | -29.0% | +42.5% | -29.7% | -1.8% | +1.7% | +7.2% | +0.3% | +1.3% | +0.5% | +0.3% | |
| – | – | -15.2% | +5.6% | +22.3% | -0.1% | -5.9% | +0.4% | -8.4% | +19.9% | -3.7% | +6.7% | |
| – | – | -9.6% | +79.7% | +0.0% | +43.6% | -1.8% | -41.8% | +368.8% | -9.3% | +5.1% | -98.6% | |
| – | – | -8.8% | +4.9% | +17.3% | -4.4% | -7.2% | +2.5% | -28.1% | +31.4% | -9.4% | +38.3% | |
| – | – | -42.2% | +79.7% | -46.7% | -1.0% | +4.6% | +11.8% | +3.3% | +3.1% | +2.5% | -0.6% | |
| – | – | +70.7% | -43.4% | +85.0% | -4.3% | -0.6% | +0.6% | -2.9% | -1.6% | -1.9% | -2.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -4.6% | +0.1% | -23.1% | +29.6% | +8.6% | +0.0% | +0.4% | -0.4% | +0.0% | -0.4% | +0.4% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.